Weekly Spotlight - 07.11.24

Community

We want to hear your story!

Fill in the form to share your experiences and any challenges you’ve faced living with your condition, for a chance to be featured in one of our weekly newsletters!

In the News

Participate in Myasthenia Gravis Work Impact Survey Today

The MAA and University of the Sunshine Coast invite individuals with Myasthenia Gravis to participate in a survey. Led by Dr. Michele Verdonck, the research aims to identify factors affecting work ability. Participants will complete a 30-minute anonymous survey to help improve working conditions for those with MG.

COVID-19 Impact on Myasthenia Gravis Patients: Key Findings and Insights

The study highlights that COVID-19 can worsen myasthenia gravis symptoms, especially in severe cases. Despite vaccinations, many patients contracted COVID-19, but treatments like corticosteroids didn't increase infection risk. Older age and severe MG history raised severe infection risks. Personalised treatment is advised for managing exacerbations.

Early Myasthenia Gravis Diagnosis: Overcoming Misdiagnosis Challenges

The study highlights the challenge of diagnosing myasthenia gravis (MG) due to its fluctuating symptoms and similarity to other diseases. Misdiagnosis is common, influenced by social determinants of health. Enhancing MG awareness in medical education is crucial for timely diagnosis and appropriate referrals, fostering better patient outcomes.

Myasthenia Gravis: Balancing Traditional and New Therapies

In a debate on myasthenia gravis treatment, Dr. Claytor supports traditional therapies like corticosteroids for their affordability and effectiveness. Dr. Guidon highlights their side effects and advocates for newer, targeted treatments. Both perspectives aim to improve patient outcomes, emphasising the need for safer, more effective options.